H.R. 298 · 114th Congress
Medical Testing Availability Act of 2015
- Stage
- In committee
- Sponsor
- Michael Burgess
- Introduced
- 2015-01-13
- Latest action
- 2015-01-16 · Referred to the Subcommittee on Health.
Summary
Medical Testing Availability Act of 2015
This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a product labeled for research use only from being deemed adulterated or misbranded on the basis that its manufacturer or distributor: (1) sells the product to an end user who uses the product for a purpose other than research, or (2) engages in business communications with an end user regarding the product.